Search Tag: Cancer Diagnostics
2025 16 May
Clear cell renal cell carcinoma (ccRCC) represents the most common subtype of kidney cancer and remains a clinical challenge due to its variable progression and risk of recurrence. Despite early detection and treatment through surgery or ablation, up to one-third of cases may relapse, necessitating accurate risk assessment prior to treatment....Read more
2025 16 May
Clear cell renal cell carcinoma (ccRCC) represents the most common subtype of kidney cancer and remains a clinical challenge due to its variable progression and risk of recurrence. Despite early detection and treatment through surgery or ablation, up to one-third of cases may relapse, necessitating accurate risk assessment prior to treatment....Read more
2025 08 Apr
Sectra signs distribution agreement with pathology AI vendor Paige.AI (Paige). The applications from Paige will be the first AI applications for pathology available via Sectra through a single contract, a single hosting solution, and a single vendor for implementation, integration and support. Following this new distribution contract, Sectra’s fully...Read more
2025 08 Apr
Sectra signs distribution agreement with pathology AI vendor Paige.AI (Paige). The applications from Paige will be the first AI applications for pathology available via Sectra through a single contract, a single hosting solution, and a single vendor for implementation, integration and support. Following this new distribution contract, Sectra’s fully...Read more
2025 08 Apr
Sectra signs distribution agreement with pathology AI vendor Paige.AI (Paige). The applications from Paige will be the first AI applications for pathology available via Sectra through a single contract, a single hosting solution, and a single vendor for implementation, integration and support. Following this new distribution contract, Sectra’s fully...Read more
2025 03 Apr
Strategic acquisition creates a leading oncology platform in Switzerland, with super-specialisation in breast and prostate cancer and an integrated care pathway Affidea Group, a leading pan-European provider of specialist healthcare services including cancer care, advanced diagnostic imaging and community-based polyclinics, today announced...Read more
2024 30 Nov
Intratumoural heterogeneity is a significant challenge in modern oncology, complicating accurate diagnosis and effective treatment planning. While widely employed, single-site biopsies often fail to capture the full range of genomic, molecular and histological variations within a tumour. As a result, diagnostic accuracy is compromised, and treatment...Read more
2024 30 Nov
Dynamic FDG PET/CT imaging has significantly advanced the diagnosis and management of gynaecological cancers by enhancing precision in distinguishing pathological from physiological uptake. Conventional static imaging often struggles with false positives, particularly in regions like the abdomen and pelvis, where physiological activity can mimic...Read more
2024 25 Nov
Advancements in imaging technologies are transforming the diagnosis and management of cancer. Among these, Immuno-PET/CT imaging targeting the Trophoblast cell surface antigen 2 (Trop2) biomarker is emerging as a revolutionary tool. A recent study published in the Journal of Nuclear Medicine highlights the development of novel Trop2-targeting...Read more
2024 16 Nov
Breast cancer remains a critical health concern globally, with early detection essential to improving treatment outcomes and increasing survival rates. In recent years, machine learning (ML) has emerged as a powerful tool in the medical field, enhancing diagnostic accuracy by offering refined predictive models that help identify relevant features...Read more
2024 16 Nov
Breast cancer remains a critical health concern globally, with early detection essential to improving treatment outcomes and increasing survival rates. In recent years, machine learning (ML) has emerged as a powerful tool in the medical field, enhancing diagnostic accuracy by offering refined predictive models that help identify relevant features...Read more
2024 04 Jun
International medical imaging IT and cybersecurity company Sectra has launched a new diagnostic IT module for genomics within molecular pathology, developed in collaboration with the University of Pennsylvania Health System in the US. The new solution, now clinically live, enables hospitals to predict how an individual cancer patient may respond...Read more